Global Nutritional IV Solution Business to Begin in Earnest

Osang Healthcare (036220) announced on the 24th that it will begin actively pursuing its global nutritional IV solution business following WiseMedi's acquisition of Good Manufacturing Practice (GMP) certification for its Jincheon Plant 2. WiseMedi is a specialized IV solution company.

The company plans to gradually expand overseas sales of WiseMedi's nutritional IV solutions, leveraging the global sales network established through its in vitro diagnostics (IVD) business and its overseas licensing and distribution capabilities.

Full Article : Osang Healthcare's Investment Firm Wise Medi Acquires GMP Certification for Jincheon Second Plant